Clinical Trial Update: Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors [Phase 1]

View source ↗

Summary

A Phase 1 trial is evaluating adding Pedmark (sodium thiosulfate) to cisplatin chemotherapy to reduce cisplatin-induced hearing loss in men with Stage II-III me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-seminomatous Germ Cell Tumor
• Testicular Cancer
• Testicular Germ Cell Tumor
• Testicular Seminoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Pedmark (sodium thiosulfate)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Hearing Loss, Metastatic Malignant Germ Cell Tumor | Phase 1 | Status: RECRUITING